Clinical and experimental medicineNov 6, 2021

Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu's Arteritis: Shared Causes and Treatment Insights

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Apr 2, 2026

Abstract

Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are associated with extensive vascular remodeling leading to occlusion and stenosis.

GCA is frequently linked with polymyalgia rheumatica (PMR).
The underlying mechanisms of GCA/PMR and TAK remain hypothetical.
Similarities in immunopathology suggest a potential connection between GCA/PMR and TAK.
Key features of the disease continuum include loss of tolerance, breakdown of tissue barriers, and granulomatous vasculitis.
Further statistically powered studies are needed to validate the observed correlations.
Inhibition of the interleukin-6 axis may be central to treating GCA/PMR and TAK.

Simplified

Giant cell arteritis (GCA), frequently associated with polymyalgia rheumatica (PMR), and Takayasu's arteritis (TAK) are characterized by extensive vascular remodeling that results in occlusion and stenosis. The pathophysiological mechanisms underlying the onset of GCA/PMR and TAK are still hypothetical. However, similarities and differences in the immunopathology and clinical phenotypes of these diseases point toward a possible link between them. The loss of tolerance in the periphery, a breakdown of tissue barriers, and the development of granulomatous vasculitis define a disease continuum. However, statistically powered studies are needed to confirm these correlations. In addition to glucocorticoids, inhibition of the interleukin-6 axis has been proposed as a cornerstone in the treatment of GCA/PMR and TAK. Novel biologic agents targeting the pathogenic pathway at various levels hold promise to achieve glucocorticoid-free sustained remission.

Full Text

Full text is available at the source.

View Full Text ↗

Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu's Arteritis: Shared Causes and Treatment Insights

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief